SCHEMBL6299079

SCHEMBL6299079

CCCC(=O)OCCc1nccc(OS(=O)(=O)C(F)(F)F)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 3/20 0.36
ALDH1A1 P00352 2/20 0.32
KMT2A Q03164 3/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
MAPK1 P28482 2/20 0.31
S1PR4 O95977 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31
S1PR1 P21453 1/20 0.31
STAT3 P40763 1/20 0.31
STAT1 P42224 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TLR9 Q9NR96 1/20 0.31
KDM4E B2RXH2 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
HTT P42858 1/20 0.31
CXCR2 P25025 1/20 0.31
HTR1A P08908 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293194 0.76 L3MBTL1 (0.33) KMT2ACXCR2PDE4APDE4CPDE4D
SCHEMBL6299075 0.76 L3MBTL1 (0.33) KMT2ACXCR2PDE4APDE4CPDE4D
SCHEMBL23714717 0.67 PDE4A (0.35) HTR1DPDE4APDE4CPDE4D
SCHEMBL6586369 0.67 HRH3 (0.43) KMT2AHSD17B10KDM4E
SCHEMBL22124736 0.66 PDE4A (0.40) CXCR2PDE4APDE4CPDE4D
SCHEMBL3946288 0.66 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2MAPK1LMNAHPGD
SCHEMBL29174905 0.66 KMT2A (0.43) TOP2AALDH1A1KMT2ASMN1; SMN2LMNA
SCHEMBL7489299 0.65 SORD (0.53)
SCHEMBL6294566 0.65 SORD (0.39) TOP2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL6293205 0.65 SORD (0.39) TOP2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936600-B2 Sorbitol dehrydrogenase inhibitors PFIZER INC (US) 2005-08-30 US disclosed
US-6869943-B2 Sorbitol dehydrogenase inhibitors PFIZER INC (US) 2005-03-22 US disclosed
US-20050020578-A1 Sorbitol dehydrogenase inhibitors PFIZER INC. 2005-01-27 US disclosed
US-20040077671-A1 Sorbitol dehydrogenase inhibitors CHU-MOYER MARGARET Y (US) 2004-04-22 US disclosed
US-6660740-B1 Sorbitol dehydrogenase inhibitors PFIZER INC 2003-12-09 US disclosed
US-6602875-B2 Sorbitol dehydrogenase inhibitors PFIZER INC 2003-08-05 US disclosed
US-20030065179-A1 Sorbitol dehydrogenase inhibitors CHU-MOYER MARGARET Y (US) 2003-04-03 US disclosed
US-6414149-B1 TREATING DIABETES, TREATING OR PREVENTING DIABETIC COMPLICATIONS PFIZER INC. 2002-07-02 US disclosed
EP-1185275-A1 AMINOPYRIMIDINES AS SORBITOL DEHYDROGENASE INHIBITORS Pfizer Products Inc. (US) 2002-03-13 EP disclosed
WO-2000059510-A1 AMINOPYRIMIDINES AS SORBITOL DEHYDROGENASE INHIBITORS PFIZER PRODUCTS INC. (US) 2000-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020578-A1 Sorbitol dehydrogenase inhibitors SLC5A1, SORD, SLC5A2 TOP2A 4483/4885ALDH1A1 26/4885KMT2A 3908/4885
US-20040077671-A1 Sorbitol dehydrogenase inhibitors SLC5A1, SORD, SLC5A2 TOP2A 4060/4885ALDH1A1 25/4885KMT2A 4011/4885
US-20030065179-A1 Sorbitol dehydrogenase inhibitors SLC5A1, SORD, SLC5A2 TOP2A 4060/4885ALDH1A1 25/4885KMT2A 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.